[go: up one dir, main page]

ES2121949T3 - Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos. - Google Patents

Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.

Info

Publication number
ES2121949T3
ES2121949T3 ES93305090T ES93305090T ES2121949T3 ES 2121949 T3 ES2121949 T3 ES 2121949T3 ES 93305090 T ES93305090 T ES 93305090T ES 93305090 T ES93305090 T ES 93305090T ES 2121949 T3 ES2121949 T3 ES 2121949T3
Authority
ES
Spain
Prior art keywords
trioxygenates
useful
benzene derivatives
antagonists
leucotrene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93305090T
Other languages
English (en)
Inventor
Michael Joseph Sofia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2121949T3 publication Critical patent/ES2121949T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

ESTA INVENCION PROPORCIONA DERIVADOS DE BENCENO 1,2,4 RIOXIGENADOS, QUE SON FORMULACIONES DE LEUKOTRIENE B4, ANTAGONISTAS, DE AQUELLOS DERIVADOS, Y UN METODO DE UTILIZAR TALES DERIVADOS PARA EL TRATAMIENTO DE CONDICIONES CARACTERIZADAS POR UN EXCESO DE LIBERACION DE LEUKOTRIENES.
ES93305090T 1992-07-01 1993-06-29 Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos. Expired - Lifetime ES2121949T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/907,492 US5352690A (en) 1992-07-01 1992-07-01 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists

Publications (1)

Publication Number Publication Date
ES2121949T3 true ES2121949T3 (es) 1998-12-16

Family

ID=25424188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93305090T Expired - Lifetime ES2121949T3 (es) 1992-07-01 1993-06-29 Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.

Country Status (6)

Country Link
US (1) US5352690A (es)
EP (1) EP0579412B1 (es)
JP (1) JPH0680566A (es)
CA (1) CA2095487A1 (es)
DE (1) DE69321411T2 (es)
ES (1) ES2121949T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090836A (en) * 1996-02-02 2000-07-18 Merck & Co., Inc. Benzisoxazole-derived antidiabetic compounds
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US6020382A (en) * 1996-02-02 2000-02-01 Merck & Co., Inc. Method of treating diabetes and related disease states
US5847008A (en) * 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US5916922A (en) * 1996-12-03 1999-06-29 Eli Lilly And Company Phenyl glyoxamides as SPLA2 inhibitors
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
AU9287401A (en) 2000-09-27 2002-04-08 Merck & Co Inc Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
JP4350946B2 (ja) * 2000-10-31 2009-10-28 メルク エンド カムパニー インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
US7524882B2 (en) * 2002-07-30 2009-04-28 Merck & Co., Inc. PPAR alpha selective compounds for the treatment of dyslipidemia and other lipid disorders
HUE032540T2 (en) * 2004-06-24 2017-09-28 Vertex Pharma Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US20090105272A1 (en) * 2005-12-24 2009-04-23 Grootenhuis Peter D J Prodrugs of modulators of ABC transporters
CA2635581C (en) * 2005-12-28 2017-02-28 Vertex Pharmaceuticals Incorporated Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
EP2821400B1 (en) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
MY170724A (en) 2012-01-27 2019-08-27 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
RU2692779C2 (ru) 2012-02-27 2019-06-27 Вертекс Фармасьютикалз Инкорпорейтед Фармацевтическая композиция и ее введения
RU2749213C2 (ru) 2014-10-07 2021-06-07 Вертекс Фармасьютикалз Инкорпорейтед Сокристаллы модуляторов регулятора трансмембранной проводимости при кистозном фиброзе

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
SU469247A3 (ru) * 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
DE3169761D1 (en) * 1981-01-09 1985-05-09 Fisons Plc Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them
EP0061800B1 (en) * 1981-03-24 1985-08-28 FISONS plc Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
ZA875319B (en) * 1986-08-15 1988-02-15 F. Hoffmann-La Roche & Co. Aktiengesellschaft Use of dihydro benzopyran derivatives
US4945099A (en) * 1987-01-12 1990-07-31 Eli Lilly And Company Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0336068A1 (en) * 1988-02-11 1989-10-11 F. Hoffmann-La Roche Ag Phenoxyalkoxy-3,4-dihydro-2H-1-benzopyran derivatives
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

Also Published As

Publication number Publication date
CA2095487A1 (en) 1994-01-02
DE69321411T2 (de) 1999-03-25
DE69321411D1 (de) 1998-11-12
EP0579412B1 (en) 1998-10-07
US5352690A (en) 1994-10-04
EP0579412A1 (en) 1994-01-19
JPH0680566A (ja) 1994-03-22

Similar Documents

Publication Publication Date Title
ES2121949T3 (es) Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.
ES2019987B3 (es) Agentes antiinflamatorios.
ES2045110T3 (es) Mejoras en o relacionadas con antagonistas de leucotrienos.
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ES2190430T3 (es) Nuevas sulfonamidas.
CO4290353A1 (es) Agonistas de estrogeno
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
AR005987A1 (es) Terapia combinada para la osteoporosis
ES2164182T3 (es) Benzociclopentanoxazolidinonas que contienen heteroatomos con actividad antibacteriana.
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
ES2164088T3 (es) Antagonistas de la sustancia p para el tratamiento de la emesis.
ES2166807T3 (es) Piridazinonas y su uso como fungicidas.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
ES2179138T3 (es) Poliisocianatos que presentan grupos alofanato basados en difenilmetanodiisocianato con grupos isocianato predominante o completamente bloqueados.
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
AR016981A2 (es) Polipeptidos sinteticos
ES2043798T3 (es) Un metodo para preparar las prostaglandinas e.
PT874625E (pt) Derivados de indano para composicoes antipsicoticas
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
MX9205358A (es) Compuestos para tratar enfermedades relacionadas con leucotrieno.
ES2170785T3 (es) Procedimiento para la fabricacion de arilpirroles insecticidas a traves de productos intermedios de oxazolamina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579412

Country of ref document: ES